找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibodies; Volume 1: Production G. Subramanian Book 2004 Springer Science+Business Media New York 2004 HIV.cancer.cancer therapy.developme

[復(fù)制鏈接]
樓主: Harrison
31#
發(fā)表于 2025-3-26 21:22:08 | 只看該作者
32#
發(fā)表于 2025-3-27 05:10:28 | 只看該作者
Large-Scale Production of Therapeutic Antibodies: Considerations for Optimizing Product Capture andlin, most of the initial wave of biotechnology products launched in the 1980s and 1990s were peptide hormones and enzymes licensed for indications with relatively small patient populations and for short-term rather than chronic use. Consequently, the market requirement for these products was frequently in the low kilogram range.
33#
發(fā)表于 2025-3-27 07:39:36 | 只看該作者
Contract Manufacturing of Biopharmaceutical Grade Antibodies,harmaceuticals. With a significant higher number in clinical trials and the search for new recombinant proteins as a result of the human genome sequencing program it is expected that many more human antibodies will enter the market in years to come (Gura, 2002, Walsh, 2000).
34#
發(fā)表于 2025-3-27 13:23:07 | 只看該作者
35#
發(fā)表于 2025-3-27 17:01:52 | 只看該作者
36#
發(fā)表于 2025-3-27 19:47:02 | 只看該作者
Einführung in die lineare Algebraain clinical indications. Consequently a variety of antibody fragments and conjugates have been developed that address specific applications and facilitate their production using low cost, microbial expression systems. This chapter will review key considerations in the formatting of antibody fragmen
37#
發(fā)表于 2025-3-27 23:49:28 | 只看該作者
38#
發(fā)表于 2025-3-28 02:44:30 | 只看該作者
39#
發(fā)表于 2025-3-28 07:21:07 | 只看該作者
Antibody Fragments,ain clinical indications. Consequently a variety of antibody fragments and conjugates have been developed that address specific applications and facilitate their production using low cost, microbial expression systems. This chapter will review key considerations in the formatting of antibody fragmen
40#
發(fā)表于 2025-3-28 11:09:48 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 20:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
丹凤县| 宕昌县| 太仓市| 洛川县| 屯门区| 台中县| 六安市| 云霄县| 新疆| 商水县| 剑阁县| 浦北县| 青田县| 安达市| 凤台县| 金坛市| 阿拉善盟| 阿坝县| 阳山县| 泰州市| 正蓝旗| 海原县| 会同县| 滦南县| 清远市| 丹寨县| 邯郸市| 仪陇县| 平顺县| 兴义市| 定襄县| 禹州市| 改则县| 桦南县| 玉溪市| 商洛市| 巨鹿县| 涟源市| 革吉县| 个旧市| 久治县|